Clinical Research Directory
Browse clinical research sites, groups, and studies.
MDMA Therapy in Veterans With PTSD
Sponsor: Sunstone Medical
Summary
A Phase 2, single-center, fixed-dose, open-label study will explore the efficacy, safety, and tolerability of a 120 mg dose of oral MDMA followed by a supplemental dose of 60 mg MDMA in conjunction with therapy in individual versus group settings for adult veterans diagnosed with PTSD.
Official title: A Phase 2, Open-Label Study Investigating the Safety and Efficacy of MDMA-Assisted Therapy for Veterans With Posttraumatic Stress Disorder (PTSD)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2026-05-01
Completion Date
2027-08
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Interventions
MDMA
MDMA is a ring-substituted phenylisopropylamine derivative invented by the Merck pharmaceutical company in 1912.
Locations (1)
Sunstone Therapies
Rockville, Maryland, United States